Get Ready for ASCO 2019

The advances in precision medicine and immune-oncology are providing high hopes for cancer treatment.  The focus on oncology research remains strong with many promising drugs in late-stage development and a robust pipeline in the horizon, showing a decline in the duration of late-stage trials as well as fewer patient enrollment.  

Many more announcements will be made during ASCO, in June 2019.

How are those impacting your oncology developments?

Let’s make sure you have all the insights necessary for your launch readiness program, your oncology portfolio management, or your early oncology research.